THROMBOMODULIN ALFA for Thrombotic microangiopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where THROMBOMODULIN ALFA was used for Thrombotic microangiopathy.
Most Reported Side Effects for THROMBOMODULIN ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 15 | 20.8% | 7 | 7 |
| Off label use | 11 | 15.3% | 6 | 3 |
| Thrombotic microangiopathy | 11 | 15.3% | 1 | 3 |
| Disseminated intravascular coagulation | 9 | 12.5% | 4 | 5 |
| Blood alkaline phosphatase increased | 7 | 9.7% | 0 | 0 |
| Blood creatinine increased | 7 | 9.7% | 0 | 0 |
| Blood urea increased | 7 | 9.7% | 0 | 0 |
| Cardiac failure acute | 7 | 9.7% | 0 | 0 |
| Gamma-glutamyltransferase increased | 7 | 9.7% | 0 | 0 |
| Weight increased | 7 | 9.7% | 0 | 0 |
| Diarrhoea | 6 | 8.3% | 0 | 3 |
| Sepsis | 6 | 8.3% | 2 | 3 |
| Hypotension | 5 | 6.9% | 3 | 3 |
| Respiratory failure | 5 | 6.9% | 5 | 3 |
| Venoocclusive liver disease | 5 | 6.9% | 5 | 1 |
Other Indications for THROMBOMODULIN ALFA
Disseminated intravascular coagulation (23)
Product used for unknown indication (12)
Acute promyelocytic leukaemia (5)
Venoocclusive liver disease (5)
Other Drugs Used for Thrombotic microangiopathy
ECULIZUMAB (1,312)
CAPLACIZUMAB-YHDP (854)
RITUXIMAB (99)
RAVULIZUMAB-CWVZ (62)
METHYLPREDNISOLONE (56)
DEFIBROTIDE (34)
PREDNISOLONE (32)
PREDNISONE (30)
MYCOPHENOLATE MOFETIL (23)
CYCLOPHOSPHAMIDE (21)